Accent Microcell — 360° view

Accent Microcell, a company in the Pharmaceuticals industry, reported revenue of ₹175 crore and net profit of ₹31 crore for the September 2026 quarter.

Accent Microcell (NSE: ACCENTMIC-SM) closed at ₹584.85 on 20 Nov 2026, up 84.3% over the past year. Its market capitalisation is ₹1,403 crore and it trades at 24.6 times earnings.

Share price
₹584.85 (20 Nov 2026)
Market cap
₹1,403 Cr (20 Nov 2026)
P/E
24.65 (20 Nov 2026)
Revenue
₹175 Cr (September 2026 quarter)
Net profit
₹31 Cr (September 2026 quarter)
ROCE
24.9% (FY26)
ROE
18.6% (FY26)
Book value
₹127 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹731.70 / ₹295.00 (20 Nov 2026)
1-year return
84.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ACCENTMIC-SM

Incorporated in 2012, Accent Microcell Ltd manufactures Pharmaceutical Excipients

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.